Testing effectiveness (Phase 2)Looking for participantsNCT07284667
What this trial is testing
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Who this might be right for
Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc. 153